Previous 10 | Next 10 |
Medpace supports the biopharmaceutical industry with state of the art research methods to accelerate the approval of drugs. The CRO market is highly competitive, but the CEO specializes in a niche that allows almost predictable sales for the upcoming years. The company is profitab...
Investing early in biotech and pharmaceutical companies can lead to some massive multi-bagger returns. However, these returns almost always come with vast amounts of risk and volatility tied to the pipeline of products. These risks seem almost unavoidable when looking at stocks with...
MedPace Holdings (NASDAQ:MEDP) is probably not a stock many Canadian investors are familiar with. However, it is definitely one that should be on your radar. Over the past month, MedPace stock is up over 18%. For the year, it is up over 60%. Over the past five years, it has delivere...
The major US equity indices moved in concert, but the big disappointment so far this year has been small caps. Energy is clearly where the action is this year. After spending years at the bottom of the tables, Natural Gas, Gasoline, and Crude Oil now lead the pack. For furth...
Image source: The Motley Fool. Medpace Holdings, Inc. Common Stock (NASDAQ: MEDP) Q3 2021 Earnings Call Oct 26, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: Medpace Holdings, Inc. Common Stock (MEDP) Q3 2021 Earn...
Medpace Holdings, Inc. (MEDP) Q3 2021 Earnings Conference Call October 26, 2021 09:00 AM ET Company Participants Lauren Morris - Director of Investor Relations August Troendle - CEO Jesse Geiger - President Kevin Brady - CFO Conference Call Participants John Kreger - William Blair Donald Hook...
Revenue of $295.6 million in the third quarter of 2021 increased 28.3% from revenue of $230.4 million for the comparable prior-year period, representing a backlog conversion rate of 17.0%. Net new business awards were $408.0 million in the third quarter of 2021, representing...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2021 financial results after the market close on Monday, October 25, 2021. The Company will host a conference call the following morning, Tuesday, October 26, 2021, at 9...
naphtalina/iStock via Getty Images Medpace (MEDP) shed ~5.7% on Wednesday to witness its biggest one-day loss in three months despite posting better-than-expected Q2 financials the previous day. Commenting on the results, Baird says the company’s performance relative to rival cont...
Image source: The Motley Fool. Medpace Holdings, Inc. Common Stock (NASDAQ: MEDP) Q2 2021 Earnings Call Jul 27, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: Medpace Holdings, Inc. Common Stock (MEDP) Q2 2021 Earn...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...